Literature DB >> 12482419

A new series of potent benzodiazepine gamma-secretase inhibitors.

Ian Churcher1, Kate Ashton, John W Butcher, Earl E Clarke, Timothy Harrison, Huw D Lewis, Andrew P Owens, Martin R Teall, Susie Williams, Jonathan D J Wrigley.   

Abstract

A new series of benzodiazepine-containing gamma-secretase inhibitors with potential use in the treatment of Alzheimer's disease is disclosed. Structure-activity relationships of the pendant hydrocinnamate side-chain which led to the preparation of highly potent inhibitors are described.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12482419     DOI: 10.1016/s0960-894x(02)00909-5

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  3 in total

1.  Three-dimensional quantitative structure-activity relationship (3D-QSAR) studies of various benzodiazepine analogues of gamma-secretase inhibitors.

Authors:  Tarnvir Sammi; Om Silakari; Muttineni Ravikumar
Journal:  J Mol Model       Date:  2008-12-06       Impact factor: 1.810

Review 2.  The Benzodiazepine-Dementia Disorders Link: Current State of Knowledge.

Authors:  Antoine Pariente; Sophie Billioti de Gage; Nicholas Moore; Bernard Bégaud
Journal:  CNS Drugs       Date:  2016-01       Impact factor: 5.749

Review 3.  Tumor microenvironment pathways: Cross regulation in breast cancer metastasis.

Authors:  Rama Rao Malla; P Kiran
Journal:  Genes Dis       Date:  2020-12-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.